Understanding Mootraghata In Ayurveda With Special Reference To Benign Prostatic Hyperplasia: A Conceptual Review

Abstract

Benign Prostatic Hyperplasia (BPH) represents a significant global health challenge, characterized by lower urinary tract symptoms (LUTS) that impact the quality of life for aging men. In parallel, Ayurvedic medicine describes a spectrum of urinary disorders under the umbrella term Mootraghata, which shares considerable symptomatic and pathophysiological commonalities with BPH. This conceptual review aims to bridge the understanding between these two medical paradigms, exploring their parallels in etiology, pathogenesis, clinical features, and therapeutic strategies. The analysis reveals that Mootraghata functions as a broad syndrome encompassing various urinary pathologies, with specific subtypes like Vatashteela demonstrating a close resemblance to BPH. Central to Ayurvedic understanding is the vitiation of Apana Vayu and the suppression of natural urges (vegavarodha), which offer a unique, holistic perspective on the dynamic component of bladder outlet obstruction. Furthermore, the involvement of Kapha and Meda Dhatu aligns with the static component of prostatic enlargement. Traditional Ayurvedic therapies, particularly Basti Karma (including Matra Basti and Uttarbasti) and specific herbal formulations like Varuna, Shilajit, Kanchanara Guggulu, and Gokshura, are discussed for their potential to address BPH-like symptoms by balancing Doshas and supporting urogenital health. This review underscores the potential for an integrative approach, leveraging the strengths of both systems for comprehensive BPH management and prevention.